Treatment and outcome of children and adolescents with N-methyl-d-aspartate receptor encephalitis-Reference-Cited by-同舟云学术

Treatment and outcome of children and adolescents with N-methyl-d-aspartate receptor encephalitis

Published:2015-05-19 Issue:8 Volume:262 Page:1859-1866
ISSN:0340-5354
Container-title:Journal of Neurology
language:en
Short-container-title:J Neurol

Author:

Zekeridou Anastasia,Karantoni Evgenia,Viaccoz Aurélien,Ducray François,Gitiaux Cyril,Villega Frédéric,Deiva Kumaran,Rogemond Veronique,Mathias Elodie,Picard Géraldine,Tardieu Marc,Antoine Jean-Christophe,Delattre Jean-Yves,Honnorat Jerome

Publisher

Springer Science and Business Media LLC

Subject

Clinical Neurology,Neurology

Link

http://link.springer.com/content/pdf/10.1007/s00415-015-7781-9.pdf

Reference24 articles.

1. Dalmau J, Tu E, Rossi JE, Voloschin A, Baehring JM, Shimazaki H, Koide R, King D, Mason W, Sansing LH, Dichter MA, Rosenfeld MR, Lynch DR (2007) Paraneoplastic anti—N-methyl-d-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 61:25–36. doi: 10.1002/ana.21050

2. Florance NR, Davis RL, Lam C, Szperka C, Zhou L, Ahmad S, Campen CJ, Moss H, Peter N, Gleichman AJ, Glaser CA, Lynch DR, Rosenfeld MR, Dalmau J (2009) Anti—N-methyl-d-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol 66:11–18. doi: 10.1002/ana.21756

3. Irani SR, Bera K, Waters P, Zuliani L, Maxwell S, Zandi MS, Friese Ma, Galea I, Kullmann DM, Beeson D, Lang B, Bien CG, Vincent A (2010) N-methyl-d-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain 133:1655–1667. doi: 10.1093/brain/awq113

4. Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R (2011) Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 10:63–74. doi: 10.1016/S1474-4422(10)70253-2

5. Titulaer MJ, McCracken L, Gabilondo I, Armangué T, Glaser C, Iizuka T, Honig LS, Benseler SM, Kawachi I, Martinez-Hernandez E, Aguilar E, Gresa-Arribas N, Ryan-Florance N, Torrents A, Saiz A, Rosenfeld MR, Balice-Gordon R, Graus F, Dalmau J (2013) Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 12:157–165. doi: 10.1016/S1474-4422(12)70310-1

Cited by 101 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of rituximab treatment for anti-N-methyl-D-aspartate receptor encephalitis without tumor in children;Pediatric Neurology;2024-09

2. Inhibition of NLRP3 inflammasome alleviates cognitive deficits in a mouse model of anti-NMDAR encephalitis induced by active immunization;International Immunopharmacology;2024-08

3. Pediatric Autoimmune Encephalitis: A Nationwide Study in Latvia;Neuropediatrics;2024-07-15

4. Global study of anti-NMDA encephalitis: a bibliometric analysis from 2005 to 2023;Frontiers in Neurology;2024-04-22

5. Intestinal dysbiosis exacerbates susceptibility to the anti-NMDA receptor encephalitis-like phenotype by changing blood brain barrier permeability and immune homeostasis;Brain, Behavior, and Immunity;2024-02